Johnson & Johnson Reports Q4 and Full-Year 2023 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Johnson & Johnson (JNJ) tops revenue estimates, reiterates forecast
January 23, 2024 6:27 AM ESTJohnson & Johnson's (NYSE: JNJ) reported today fourth-quarter results that exceeded analyst expectations.
Adjusted earnings per share (EPS) came in at $2.29, slightly surpassing the average analyst estimate of $2.28. The company also reported sales of $21.40 billion for the quarter, beating the estimated $21.00 billion.
Looking ahead,... More
Johnson & Johnson (JNJ) Tops Q4 EPS by 1c, Beats on Revenue; Reaffirms FY24 Growth Targets
January 23, 2024 6:20 AM EST(Updated - January 23, 2024 6:22 AM EST)
Johnson & Johnson (NYSE: JNJ) reported Q4 EPS of $2.29, $0.01 better than the analyst estimate of $2.28. Revenue for the quarter came in at $21.4 billion versus the consensus estimate of $21 billion.
The company re-confirms guidance for 2024 with operational sales growth of... More
